These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16361839)

  • 21. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
    Fleischmann EH; Bower JD; Salahudeen AK
    Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysis.
    Hocher B; Kalk P; Godes M; Liefeldt L; Ziebig R; Stasch JP; Quaschning T; Pfab T
    Kidney Blood Press Res; 2008; 31(5):360-6. PubMed ID: 19023219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment.
    La Manna G; Pizza F; Persici E; Baraldi O; Comai G; Cappuccilli ML; Centofanti F; Carretta E; Plazzi G; Colì L; Montagna P; Stefoni S
    Nephrol Dial Transplant; 2011 Jun; 26(6):1976-83. PubMed ID: 21056943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of sudden death in patients with chronic renal failure and hemodialysis].
    Panaghiu L; Veisa G; Covic A; Alexa ID; Arsenescu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):290-5. PubMed ID: 15688801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
    Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
    Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational study on markers of cardiovascular risk in renal patient: conventional hemodialysis vs. haemofiltration online.
    Melero-Rubio E; Párraga-Díaz M; Gómez-Sánchez MP; Pellicer-Villaescusa S; Merchán-Mayado E
    J Ren Care; 2009 Dec; 35(4):201-4. PubMed ID: 19909413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient selection to peritoneal dialysis versus hemodialysis according to comorbid conditions.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):20-6. PubMed ID: 1442771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular disease in terminal end-stage renal failure--epidemiological aspects].
    Kessler M
    Nephrologie; 2002; 23(7):361-5. PubMed ID: 12500422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil.
    Sesso R; da Silva CB; Kowalski SC; Manfredi SR; Canziani ME; Draibe SA; Elgazzar HA; Ferraz MB
    Int J Technol Assess Health Care; 2007; 23(1):126-30. PubMed ID: 17234026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased mortality of elderly female peritoneal dialysis patients with diabetes--a descriptive analysis.
    Maitra S; Jassal SV; Shea J; Chu M; Bargman JM
    Adv Perit Dial; 2001; 17():117-21. PubMed ID: 11510257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.
    Hwang SJ; Yang WC; Lin MY; Mau LW; Chen HC;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2616-24. PubMed ID: 20519231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.